The Ligustrazin Phosphate Injection
Date: 06/12/2018 | Source: Rodong Sinmun (En) | Read original version at source
Of late, the Kongang Joint Corporation developed a Ligustrazin phosphate injection after years of hard work. It is efficacious against cerebral thrombosis and myocardial infarction.
As is widely known, ligustrazin not only contains the aggregation of thrombocytes and brings about vasodilation but also restores to the original state the nerve tissues which dysfunction due to cerebral thrombosis.
Angelicas, Ephedra sinica and other medicinal herbs contain a small amount of ligustrazin. Therefore, it took a long time to cure one of a diseases with the drugs prepared from them, and what was worse, they proved not so effective. But the injection is popular for efficacy.
The medical institutions of Pyongyang made a clinical examination of the injection and proved that it had far greater effect on cerebral thrombosis than its ordinary predecessors, was efficacious against myocardial infarction by 90% and served to alleviate or prevent the headache, dizziness, paralysis of hands and feet, aphasia and the like resulting from cerebral circulation disorders.
Pang Kyong Chan